Glukoza Braun (Glucose Monohydrate)

Glukoza Braun is employed in clinical settings where rapid glucose supplementation or fluid balance is required. It is commonly used for:

• Treatment of hypoglycemia in patients unable to take oral glucose.
• Providing caloric support as part of parenteral nutrition regimens.
• Maintaining fluid and electrolyte balance during surgery or critical illness.
• Diluting or reconstituting other intravenous medications when a glucose carrier is needed.
• Supporting patients with prolonged fasting or severe malnutrition.

Glukoza Braun may cause a range of reactions, most of which are related to its glucose content and intravenous administration.

Common

• Transient hyperglycemia or elevated blood glucose levels.
• Local irritation at the infusion site.
• Mild nausea or abdominal discomfort.
• Fluid overload in patients with compromised cardiac function.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reaction such as rash, pruritus, or anaphylaxis.
• Electrolyte imbalance, particularly hyponatremia.
• Venous thrombosis or phlebitis at the catheter site.

When using Glukoza Braun, clinicians should consider several safety factors to minimize risk. Important precautions include:

• Assess baseline blood glucose and monitor levels frequently during infusion.
• Evaluate cardiac and renal function to avoid fluid overload.
• Use aseptic technique to prevent catheter‑related infections.
• Adjust infusion rate in patients with diabetes or insulin therapy.
• Review electrolyte status, especially sodium and potassium, before and during treatment.
• Consider alternative carbohydrate sources if the patient has a known glucose intolerance.

Glukoza Braun can interact with other medications or clinical conditions, requiring careful management.

Avoid

• Co‑administration with high‑dose insulin without glucose monitoring, which may precipitate severe hypoglycemia.
• Simultaneous infusion of potassium chloride in concentrations that could cause hyperkalemia.

Use with caution

• Concurrent use of diuretics that may alter fluid balance.
• Administration alongside other hyperosmolar solutions, which can increase the risk of osmotic injury.
• Patients receiving corticosteroids, as they may exacerbate hyperglycemia.
• Situations where rapid electrolyte shifts are expected, such as during massive transfusion.